Hyliion is trading at $3.45, down 5.5%, alongside broad market weakness after hotter-than-expected September inflation renewed interest-rate concerns.
- The S&P 500 was down 0.61%, while the Nasdaq Composite fell 0.91%.
- No confirmed company-specific catalyst for the live drop was identified.
- Shareholder-law-firm notices citing an October 27 lead-plaintiff deadline have circulated, but available reporting does not establish them as the cause of this morning’s move.